Vascular Access Devices Market Outlook (2022-2033)

Increasing Demand for Hemodialysis

Chronic kidney disorders are becoming more common worldwide as people age and adopt less healthy lifestyles, such as eating poorly, drinking alcohol, and smoking. As economies grow and people have more disposable income, unhealthy habits are also increasing. Poor sleep and eating patterns are major reasons for the rise in kidney failure, which leads to greater demand for regular hemodialysis treatment.

Vascular access is essential for dialysis because it connects the dialysis machine to the patient’s bloodstream, allowing for the exchange of blood between the patient and the dialysis machine. The main types of vascular access devices used in hemodialysis are arteriovenous fistulas, catheters, and artery-venous grafts. Arteriovenous fistulas are considered the best option for this purpose. As the number of people requiring hemodialysis increases, the demand for vascular access devices is also growing.

• Around 2 million people worldwide have kidney disease or failure, including 750,000 new cases each year in the United States. In the U.S., over 100,000 patients are waiting for a kidney transplant, and the need for kidney donors is rising by 8% each year.
• The average annual cost of hemodialysis in the Medicare system in the United States is approximately $90,000 per patient, totaling $28 billion.

Technological Advancement in the Vascular Access Device

Continued investment in healthcare and pharmaceutical infrastructure is helping to develop new treatments and medicines, which support the growth of vascular access devices. Increased spending on new technology in these devices is also creating more opportunities in the market.

• The FDA has approved two new devices to help prevent dysfunction. Ellipsys, manufactured by Medtronic, is a single-catheter electrocautery device that is placed using ultrasound. WavelinQ from BD is a dual-catheter device that is placed using fluoroscopy.
• The reimplementation of surgical techniques and radial artery deviation led to the development of the VasQ device by Laminate Medical, which helps support the patient's vasculature to limit the risk of arteriovenous fistula failure. Additionally, the Alio Smartwatch enables remote monitoring of patients with AV access flow surveillance.

The "Vascular access devices Market Size and Forecast (2022–2033)" report provides a detailed analysis of the market covering below areas:

• vascular access devices market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• vascular access devices market trends, as well as market dynamics such as drivers, restraints, and key opportunities
• vascular access devices market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the vascular access devices market
• Detailed company profiles, including SWOT analysis

The geographical scope of the vascular access devices market report is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America. The vascular access devices market in Asia Pacific is expected to grow significantly during the forecast period.

The Asia-Pacific vascular access devices market is segmented into China, Japan, South Korea, India, Australia, and the rest of Asia. Asia Pacific is expected to see the fastest market growth during the forecast period. This is due to a growing population and higher demand for better healthcare infrastructure. An increasing number of older adults, who are more likely to have chronic diseases such as heart disease, cancer, high blood pressure, and diabetes, is also boosting the vascular access devices market in the region. For instance, in October 2023, B. Braun Medical Inc. introduced the Introcan Safety 2 IV Catheter with Multi-Access Blood Control. This new catheter is designed to prevent needlestick injuries. It also helps protect clinicians from blood exposure and lowers the risk of bloodborne pathogens during IV procedures.

The Asia Pacific vascular access devices market is expected to grow at the fastest rate during the forecast period. The increase in R&D investments by international bodies such as the China Cardiovascular Association and the American College of Cardiology, collaborating to advance cardiac care technologies, is one of the reasons behind this.

• The report includes qualitative and quantitative data in the vascular access devices market across product, route of insertion, application, end user, and geography.
• The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the vascular access devices market.
• Chapter 3 includes the research methodology of the study.
• Chapter 4 further includes ecosystem analysis.
• Chapter 5 highlights the major industry dynamics in the vascular access devices market, including factors that are driving the market, prevailing deterrents, potential opportunities, as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
• Chapter 6 discusses the vascular access devices market scenario, in terms of historical market revenues, and forecast till the year 2031.
• Chapters 7 to 11 cover vascular access devices market segments by product, route of insertion, application, end user, and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America. They cover the market value revenue forecast and factors driving the market.
• Chapter 12 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
• Chapter 13 describes the industry landscape analysis. It provides detailed descriptions of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
• Chapter 14 provides detailed profiles of the major companies operating in the vascular access devices market. Companies have been profiled on the basis of their key facts, business descriptions, products and services, financial overview, SWOT analysis, and key developments.
• Chapter 15, i.e., the appendix is inclusive of a brief overview of the company, list of abbreviations, and disclaimer.

The vascular access devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the vascular access devices market are:

• In June 2024, Tom Polen, chairman, chief executive officer and president of BD (Becton, Dickinson and Company) and Edwards Lifesciences, announced a definitive agreement under which BD will acquire the Critical Care product group of Edwards for USD 4.2 billion by opening new avenues for growth and value creation opportunities and improving the portfolio of BD smart connected care solutions.
• In November 2024, BD announced the launch of the BD Intraosseous (IO) Vascular Access System, designed to provide rapid vascular access during critical emergencies. This device is capable of delivering fluids or medication swiftly through the bone marrow cavity when traditional intravenous access is challenging. The BD IO System addresses both adult and pediatric patients by offering unique capabilities tailored to diverse anatomical needs.
• In November 2023, BD, a globally recognized medical technology company, launched an advanced ultrasound system specifically designed to enhance clinical efficiency for central venous catheters, peripherally inserted central catheters (PICCs), IV lines, and other vascular access devices.